首页 | 本学科首页   官方微博 | 高级检索  
     


Pre‐emptive rituximab for Epstein–Barr virus reactivation after haplo‐hematopoietic stem cell transplantation
Authors:Shogo Kobayashi  Hideki Sano  Kazuhiro Mochizuki  Yoshihiro Ohara  Nobuhisa Takahashi  Hitoshi Ohto  Atsushi Kikuta
Affiliation:1. Department of Pediatric Oncology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan;2. Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan
Abstract:
Keywords:anti‐thymocyte globulin  children  Epstein–  Barr virus‐related post‐transplantation lymphoproliferative disease  haploidentical hematopoietic stem cell transplantation  rituximab
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号